Quantinno Capital Management’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
Other funds holding KROS
Quantinno Capital Management's KROS Position: Q3 2026 in Review
Quantinno Capital Management increased its Keros Therapeutics (KROS) stake by 246% in Q3 2026, buying an estimated $725K and bringing the position to 93,242 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2756.
Quantinno Capital Management first reported a position in KROS in Q3 2025 and has held it in 5 quarters since. 134 funds tracked by Wall St. Rank hold KROS as of Q3 2026.
- Quantinno Capital Management held 93,242 shares of Keros Therapeutics worth $1.06M as of Q3 2026.
- Quantinno Capital Management bought 66,271 Keros Therapeutics shares in Q3 2026, an estimated $725K.
- Keros Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #2756 holding.
- Quantinno Capital Management first reported a position in Keros Therapeutics in Q3 2025 and has held it in 5 quarters since.
- 134 funds tracked by Wall St. Rank held Keros Therapeutics as of Q3 2026.
Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.